Understanding Treatment Duration and Next Steps
“How long do I need to stay on this medication?” is one of the most common questions patients ask about antidepressant treatment. It’s an important question that deserves a thoughtful, evidence-based answer. This guide provides an overview of SSRI treatment duration and helps patients understand what to expect, whether they are just starting an antidepressant, have been taking one for years, or are considering next steps.
Selective serotonin reuptake inhibitors (SSRIs) have helped millions of people find relief from depression, anxiety, and other mental health conditions. Determining how long to stay on an SSRI and when it may be appropriate to discontinue requires a personalized conversation with a healthcare provider. Recent research has provided clearer guidance on treatment duration, discontinuation syndrome, and evidence-based tapering strategies. This article reviews what current research indicates about these topics and outlines what patients can expect when working with their provider to make informed treatment decisions.
What Are SSRIs and How Do They Work?
SSRIs increase the availability of serotonin in the brain, a neurotransmitter that plays a key role in regulating mood, sleep, appetite, and anxiety. By blocking the reabsorption of serotonin, these medications allow more of it to remain active between nerve cells, promoting emotional stability and resilience.
They are commonly prescribed for conditions such as major depressive disorder, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD).
It is important to understand that SSRIs typically take at least four to six weeks to reach their full effect at therapeutic doses, and consistent daily use is essential. The brain gradually adapts to the medication, which is also why stopping suddenly can cause problems.
How Long Should You Stay on an SSRI?
There is no single “right” answer to how long someone should remain on an SSRI. Treatment duration depends on each person’s unique situation, but psychiatric guidelines provide a general framework.
Acute phase: Lasts about 6 to 12 weeks, focusing on symptom remission.
Continuation phase: Lasts 4 to 9 months after improvement to prevent relapse. Research shows that continuing antidepressant use during this time reduces relapse rates by roughly half compared to stopping.
Maintenance phase: May last a year or longer, particularly for people with multiple depressive episodes.
For those who have had three or more depressive episodes, guidelines often recommend considering long-term treatment. Other factors that influence how long someone stays on medication include the number and severity of past episodes, family history, coexisting conditions, and participation in therapy.
Signs You Might Be Ready to Discuss Stopping
The decision to stop SSRIs is highly individual, but several signs may suggest that it is time to discuss discontinuation with a provider. These include:
Symptoms have been stable for 6 to 12 months.
The patient is actively engaged in therapy or has developed effective coping strategies.
Life circumstances are relatively stable.
A reliable support system is in place.
The provider agrees that it may be reasonable to consider tapering.
Understanding when to stop antidepressants is just as important as knowing when to start them.
Critical point: Patients should never stop taking an SSRI suddenly or without medical supervision. Experts describe the decision to reduce or discontinue medication as a “collaborative inquiry,” meaning it should always be a shared process between patient and provider.
What Is SSRI Discontinuation Syndrome?
SSRI discontinuation syndrome, now formally recognized in the DSM-5-TR, occurs when the brain experiences a sudden drop in serotonin levels after medication is stopped or rapidly reduced. Research on the incidence of these symptoms has produced varied findings, largely due to differences in study design, populations, and measurement methods.
Providers often use the mnemonic FINISH to describe common symptoms:
Flu-like symptoms (fatigue, headache)
Insomnia
Nausea
Imbalance (dizziness)
Sensory disturbances, including “brain zaps” (sensations described as electrical, zapping, or buzzing in the brain)
Hyperarousal (anxiety, irritability)
It is important to differentiate discontinuation symptoms from a relapse of depression. Discontinuation symptoms usually begin within one to three days of stopping or reducing medication and improve quickly if the medication is restarted. Relapse, on the other hand, tends to develop more gradually over days to weeks. Depression itself is not considered a withdrawal symptom; its return generally indicates a recurrence of the underlying illness.
How to Safely Taper Off an SSRI
Tapering off an SSRI should always be done gradually and under professional supervision. Stopping suddenly can lead to significant discomfort and increase the risk of relapse.
A common approach involves reducing the dose by about 25 percent every two to four weeks, though smaller reductions may be needed for those who have taken medication long-term. Some patients benefit from liquid formulations that allow for precise dose adjustments. Throughout the tapering process, regular check-ins with a psychiatrist are essential. If symptoms become severe, returning to the previous dose and tapering more slowly is often the best course of action.
Supporting Mental Health During and After Medication
Research strongly supports combining a gradual taper with psychological interventions. Stopping antidepressants while receiving psychological support, such as cognitive behavioral therapy (CBT) or mindfulness-based approaches, significantly improves outcomes.
Lifestyle factors also play an important role in maintaining emotional stability. Consistent sleep routines, regular physical activity, balanced nutrition, and stress management all contribute to resilience. Some patients find it helpful to create a wellness recovery action plan, identifying early warning signs of relapse and strategies to address them.
Social support from friends, family, or peer groups can also provide encouragement and accountability during this transition.
If symptoms return after stopping medication, this is not a failure. It simply indicates that additional support may be needed. Restarting or adjusting treatment is a reasonable and responsible step. Recovery is rarely linear, and adapting treatment along the way is part of the healing process.
When Continuing Treatment Might Be the Best Option
For some people, long-term SSRI use is not only safe but also medically appropriate. Those who have experienced multiple depressive episodes, have a strong family history, or find that medication significantly improves their quality of life may benefit from continued treatment.
There is a common misconception that the goal should always be to discontinue medication. In reality, mental health treatment should be individualized. Continuing medication can be just as valid and intentional a choice as tapering off. What matters most is that the decision is made thoughtfully and collaboratively with a provider.
Next Steps: Talk with Your Provider
Anyone wondering how long to stay on an SSRI, or whether it might be time to consider tapering, should start with an open conversation with their psychiatric provider. Together, you can weigh the benefits and risks based on your medical history, current stability, and long-term goals.
At Heritage Counseling, we offer both medication management and therapy to support patients at every stage of their mental health journey. Whether you are beginning treatment, maintaining progress, or considering discontinuation, our providers are here to guide you with expertise and compassion.
To learn more or schedule an appointment, contact Heritage Counseling today at 214-363-2345.
References
Davies J, Read J. A systematic review into the incidence, severity, and duration of antidepressant withdrawal effects. Addictive Behaviors. 2019;97:111-121.
Fornaro M, et al. Antidepressant discontinuation syndrome: a state-of-the-art clinical review. European Neuropsychopharmacology. 2022;58:7-26.
Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538-546.
Kalfas M, et al. Incidence and nature of antidepressant discontinuation symptoms. JAMA Psychiatry. 2025;82(9):896-904.
Van Leeuwen E, et al. Approaches for discontinuation versus continuation of long-term antidepressant use. Cochrane Database Syst Rev. 2021.
Zaccoletti D, et al. Comparison of antidepressant deprescribing strategies in clinically remitted depression. Lancet Psychiatry. 2025;13(1):24-36.
Zwiebel SJ, Viguera AC. Discontinuing antidepressants: pearls and pitfalls. Cleveland Clinic J Med. 2022;89(1):18-26.
Gupta et al. Deprescribing in Psychiatry. Oxford University Press. 2019